Abstract:Esophageal cancer, a leading cause of cancer death worldwide, is associated with abnormal activation of the AKT signaling pathway. Xanthohumol, a prenylated flavonoid tested in clinical trials, is reported to exert anti-diabetes, anti-inflammation and anticancer activities. However, the mechanisms underlying its chemopreventive or chemotherapeutic effects remain elusive. In the present study, we found that xanthohumol directly targeted AKT1/2 in esophageal squamous cell carcinoma (ESCC). Xanthohumol significantly inhibited the AKT kinase activity in an ATP competitive manner, which was confirmed in binding and computational docking models. KYSE70, 450 and 510 ESCC cell lines highly express AKT and knockdown of AKT1/2 suppressed proliferation of these cells. Treatment with xanthohumol inhibited ESCC cell growth and induced apoptosis and cell cycle arrest at the G1 phase. Xanthohumol also decreased expression of cyclin D1 and increased the levels of cleaved caspase-3, -7 and -PARP as well as Bax, Bim<sub>s</sub> and cytochrome c in ESCC cells by downregulating AKT signaling targets, including glycogen synthase kinase 3 beta (GSK3β), mammalian target of rapamycin, and ribosomal protein S6 (S6K). Furthermore, xanthohumol decreased tumor volume and weight in patient-derived xenografts (PDXs) that highly expressed AKT, but had no effect on PDXs that exhibited low expression of AKT in vivo. Kinase array results showed that xanthohumol treatment decreased phosphorylated p27 expression in both ESCC cell lines and PDX models. Taken together, our data suggest that the inhibition of ESCC tumor growth with xanthohumol is caused by targeting AKT. These results provide good evidence for translation toward clinical trials with xanthohumol.

Xanthohumol Inhibits Colorectal Cancer Cells Via Downregulation Of Hexokinases Ii-Mediated Glycolysis

Xanthohumol Promotes Skp2 Ubiquitination Leading to the Inhibition of Glycolysis and Tumorigenesis in Ovarian Cancer

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo

Intestinal metabolite xylulose inhibits colorectal cancer by inducing apoptosis through the MAPK signalling pathway

Xanthohumol Targets the ERK1/2‑Fra1 Signaling Axis to Reduce Cyclin D1 Expression and Inhibit Non‑small Cell Lung Cancer

Xanthohumol Inhibits Non‐small Cell Lung Cancer Via Directly Targeting T‐lymphokine‐activated Killer Cell‐originated Protein Kinase

Repression of Hexokinases II-Mediated Glycolysis Contributes to Piperlongumine-Induced Tumor Suppression in Non-Small Cell Lung Cancer Cells.

Euxanthone suppresses tumor growth and metastasis in colorectal cancer via targeting CIP2A/PP2A pathway

B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2

Downregulation Of The Hexokinase Ii Gene Sensitizes Human Colon Cancer Cells To 5-Fluorouracil

Xanthohumol Inhibits Proliferation of Laryngeal Squamous Cell Carcinoma.

Resveratrol Inhibits Hexokinases II Mediated Glycolysis in Non-Small Cell Lung Cancer Via Targeting Akt Signaling Pathway

Acetylated Xylo-Oligosaccharide from Hawthorn Kernels Inhibits Colon Cancer Cells in Vitro and in Vivo

Therapeutic Inhibition of SGK1 Suppresses Colorectal Cancer

Chrysophanol Suppresses Hypoxia‐Induced Epithelial‐Mesenchymal Transition in Colorectal Cancer Cells

Silencing Hexokinase II Gene Sensitizes Human Colon Cancer Cells to 5-Fluorouracil.

Inhibition of Breast Cancer Cell Survival by Xanthohumol Via Modulation of the Notch Signaling Pathway in Vivo and in Vitro

Promotion of Ubiquitination-Dependent Survivin Destruction Contributes to Xanthohumol-Mediated Tumor Suppression and Overcomes Radioresistance in Human Oral Squamous Cell Carcinoma.

Curcumol Reduces Aerobic Glycolysis and Overcomes Chemoresistance by Inducing Cdh1-Mediated Skp2 Ubiquitination

Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action

External Qi of Yan Xin Qigong Inhibits Activation of Akt, Erk1/2 and NF-ĸB and Induces Cell Cycle Arrest and Apoptosis in Colorectal Cancer Cells